Sample | Title | Value | Rank |
GSM967852 | U87-EV human glioblastoma xenograft - Control 1 | 2.13365 | 6 |
GSM967853 | U87-EV human glioblastoma xenograft - Control 2 | 2.11206 | 6 |
GSM967854 | U87-EV human glioblastoma xenograft - Control 3 | 2.11428 | 6 |
GSM967855 | U87-EV human glioblastoma xenograft - Control 4 | 2.06091 | 6 |
GSM967856 | U87-EV human glioblastoma xenograft - Control 5 | 2.0675 | 6 |
GSM967862 | U87-EV human glioblastoma xenograft - Bevacizumab treated 1 | 2.16372 | 6 |
GSM967863 | U87-EV human glioblastoma xenograft - Bevacizumab treated 2 | 2.14122 | 6 |
GSM967864 | U87-EV human glioblastoma xenograft - Bevacizumab treated 3 | 2.08907 | 6 |
GSM967865 | U87-EV human glioblastoma xenograft - Bevacizumab treated 4 | 2.07944 | 6 |
GSM967857 | U87-EV human glioblastoma xenograft - dibenzazepine treated 1 | 2.09962 | 6 |
GSM967858 | U87-EV human glioblastoma xenograft - dibenzazepine treated 2 | 2.09476 | 6 |
GSM967859 | U87-EV human glioblastoma xenograft - dibenzazepine treated 3 | 2.08427 | 6 |
GSM967860 | U87-EV human glioblastoma xenograft - dibenzazepine treated 4 | 2.10773 | 6 |
GSM967861 | U87-EV human glioblastoma xenograft - dibenzazepine treated 5 | 2.09935 | 6 |